Stock comparison
AbbVie
ABBV$499.53BHealthcare Market cap, Sector
AnaptysBio
ANAB$1.47BHealthcare Market cap, Sector
AbbVie
ABBV 52 ANAB
Based on the combined fit scores from all four strategies. The breakdown by strategy is below.
Fit scores by strategy
Side-by-side metrics
| Metric | ABBV | ANAB |
|---|---|---|
| Market cap | Winner: $499.53B | $1.47B |
| P/E (TTM) | 102.5x | - Winner |
| EV/EBIT | Winner: 52.2x | 55.0x |
| ROIC (TTM) |
Where each one wins
The metrics with the widest gap between the two, biggest differences first.
ABBV leads on
- Debt / Equity-vs 21.8x+195%
- Net margin6.91%vs -11.53%+160%
- Dividend yield3.08%vs 0.0%+100%
- Market cap$499.53Bvs $1.47B+100%
ANAB leads on
More like ABBV
More like ANAB
Related on invest-like
For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.